Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

LIF-ting Hippo averts metastasis.

Piccolo S.

Nat Med. 2012 Oct;18(10):1463-5. doi: 10.1038/nm.2955. No abstract available.

PMID:
23042347
2.

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.

Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, Gupta S, Liang H, Lin HK, Hung MC, Ma L.

Nat Med. 2012 Oct;18(10):1511-7. doi: 10.1038/nm.2940. Epub 2012 Sep 23.

3.

The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.

Hiemer SE, Szymaniak AD, Varelas X.

J Biol Chem. 2014 May 9;289(19):13461-74. doi: 10.1074/jbc.M113.529115. Epub 2014 Mar 19.

4.

The role of leukemia inhibitory factor in tubal ectopic pregnancy.

Krishnan T, Winship A, Sonderegger S, Menkhorst E, Horne AW, Brown J, Zhang JG, Nicola NA, Tong S, Dimitriadis E.

Placenta. 2013 Nov;34(11):1014-9. doi: 10.1016/j.placenta.2013.09.003. Epub 2013 Sep 13.

PMID:
24074901
5.

Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia.

Bozec A, Bakiri L, Hoebertz A, Eferl R, Schilling AF, Komnenovic V, Scheuch H, Priemel M, Stewart CL, Amling M, Wagner EF.

Nature. 2008 Jul 10;454(7201):221-5. doi: 10.1038/nature07019. Epub 2008 Jun 11.

PMID:
18548006
6.

LacdiNAc (GalNAcβ1-4GlcNAc) contributes to self-renewal of mouse embryonic stem cells by regulating leukemia inhibitory factor/STAT3 signaling.

Sasaki N, Shinomi M, Hirano K, Ui-Tei K, Nishihara S.

Stem Cells. 2011 Apr;29(4):641-50. doi: 10.1002/stem.615.

7.

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, Daidone MG, Dupont S, Basso G, Bicciato S, Piccolo S.

Cell. 2011 Nov 11;147(4):759-72. doi: 10.1016/j.cell.2011.09.048.

8.

An anti-inflammatory role for leukemia inhibitory factor receptor signaling in regenerating skeletal muscle.

Hunt LC, Upadhyay A, Jazayeri JA, Tudor EM, White JD.

Histochem Cell Biol. 2013 Jan;139(1):13-34. doi: 10.1007/s00418-012-1018-0. Epub 2012 Aug 28.

PMID:
22926285
9.

Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade.

Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, Staccini L, Villageois P, Barhanin B, Vernallis A, Smith AG, Ailhaud G, Dani C.

J Biol Chem. 1999 Aug 27;274(35):24965-72.

10.

Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation.

Estrov Z, Samal B, Lapushin R, Kellokumpu-Lehtinen P, Sahin AA, Kurzrock R, Talpaz M, Aggarwal BB.

J Interferon Cytokine Res. 1995 Oct;15(10):905-13.

PMID:
8564713
11.

Moscatilin inhibits migration and metastasis of human breast cancer MDA-MB-231 cells through inhibition of Akt and Twist signaling pathway.

Pai HC, Chang LH, Peng CY, Chang YL, Chen CC, Shen CC, Teng CM, Pan SL.

J Mol Med (Berl). 2013 Mar;91(3):347-56. doi: 10.1007/s00109-012-0945-5. Epub 2012 Sep 8.

PMID:
22961111
12.

Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.

Dhingra K, Sahin A, Emami K, Hortobagyi GN, Estrov Z.

Breast Cancer Res Treat. 1998 Mar;48(2):165-74.

PMID:
9596488
13.

AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.

Couderc C, Boin A, Fuhrmann L, Vincent-Salomon A, Mandati V, Kieffer Y, Mechta-Grigoriou F, Del Maestro L, Chavrier P, Vallerand D, Brito I, Dubois T, De Koning L, Bouvard D, Louvard D, Gautreau A, Lallemand D.

Neoplasia. 2016 Jan;18(1):10-24. doi: 10.1016/j.neo.2015.11.010.

14.

Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.

Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS.

Mol Cancer. 2011 Jan 28;10(1):10. doi: 10.1186/1476-4598-10-10.

15.

Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.

Sudol M.

Sci Signal. 2014 Dec 9;7(355):pe29. doi: 10.1126/scisignal.aaa2710. Review.

PMID:
25492964
16.
18.

The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling.

Clahsen T, Lehmann U, Stross C, Hermanns HM, Volkmer-Engert R, Schneider-Mergener J, Heinrich PC, Schaper F.

Cell Signal. 2005 May;17(5):559-69.

PMID:
15683731
19.

NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway.

Habbig S, Bartram MP, Müller RU, Schwarz R, Andriopoulos N, Chen S, Sägmüller JG, Hoehne M, Burst V, Liebau MC, Reinhardt HC, Benzing T, Schermer B.

J Cell Biol. 2011 May 16;193(4):633-42. doi: 10.1083/jcb.201009069. Epub 2011 May 9.

20.

YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer.

Hergovich A.

Breast Cancer Res. 2012 Dec 5;14(6):326. doi: 10.1186/bcr3349.

Supplemental Content

Support Center